1
Immunophenotyping of Peripheral T Cells After T Cell Depletion With Alemtuzumab
Condition(s):Kidney TransplantLast Updated:April 10, 2019Terminated
Hide Studies Not Open or Pending
Condition(s):Kidney TransplantLast Updated:April 10, 2019Terminated
Condition(s):Kidney Failure; Surgery; Renal FailureLast Updated:January 3, 2022Terminated
Condition(s):Cirrhosis; Hepatitis C; Hepatocellular CarcinomaLast Updated:August 29, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.